{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:58:29Z","timestamp":1789815509027,"version":"4.0.1"},"reference-count":80,"publisher":"The Company of Biologists","issue":"9-10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:p>Soft-tissue sarcomas (STSs) are rare mesenchymal tumors that arise from muscle, fat and connective tissue. Currently, over 75 subtypes of STS are recognized. The rarity and heterogeneity of patient samples complicate clinical investigations into sarcoma biology. Model organisms might provide traction to our understanding and treatment of the disease. Over the past 10 years, many successful animal models of STS have been developed, primarily genetically engineered mice and zebrafish. These models are useful for studying the relevant oncogenes, signaling pathways and other cell changes involved in generating STSs. Recently, these model systems have become preclinical platforms in which to evaluate new drugs and treatment regimens. Thus, animal models are useful surrogates for understanding STS disease susceptibility and pathogenesis as well as for testing potential therapeutic strategies.<\/jats:p>","DOI":"10.1242\/dmm.005223","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T01:55:12Z","timestamp":1282010112000},"page":"557-566","source":"Crossref","is-referenced-by-count":49,"title":["Animal models of soft-tissue sarcoma"],"prefix":"10.1242","volume":"3","author":[{"given":"Rebecca D.","family":"Dodd","sequence":"first","affiliation":[{"name":"450 Research Drive, Box 91996, LSRC Building, Duke University, NC 27708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery K.","family":"Mito","sequence":"additional","affiliation":[{"name":"450 Research Drive, Box 91996, LSRC Building, Duke University, NC 27708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[{"name":"450 Research Drive, Box 91996, LSRC Building, Duke University, NC 27708, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042612465477900_b1-0030557","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1038\/sj.onc.1204599","article-title":"Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma","volume":"20","author":"Barr","year":"2001","journal-title":"Oncogene"},{"key":"2021042612465477900_b2-0030557","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1073\/pnas.0805462105","article-title":"Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage","volume":"105","author":"Berman","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b3-0030557","doi-asserted-by":"crossref","first-page":"13164","DOI":"10.1073\/pnas.93.23.13164","article-title":"Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins","volume":"93","author":"Bernasconi","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b4-0030557","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/320415a0","article-title":"A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family","volume":"320","author":"Besmer","year":"1986","journal-title":"Nature"},{"key":"2021042612465477900_b5-0030557","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02265259","article-title":"A common region of loss of heterozygosity in Wilms\u2019 tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5","volume":"97","author":"Besnard-Guerin","year":"1996","journal-title":"Hum Genet"},{"key":"2021042612465477900_b6-0030557","first-page":"1941","article-title":"Soft tissue sarcomas of adults: state of the translational science","volume":"9","author":"Borden","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2021042612465477900_b7-0030557","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199011223232105","article-title":"Altered expression of the retinoblastoma gene product in human sarcomas","volume":"323","author":"Cance","year":"1990","journal-title":"N Engl J Med"},{"key":"2021042612465477900_b8-0030557","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"2021042612465477900_b9-0030557","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2021042612465477900_b10-0030557","first-page":"1037","article-title":"Tumor suppressor genes and related molecules in leiomyosarcoma","volume":"148","author":"Dei Tos","year":"1996","journal-title":"Am J Pathol"},{"key":"2021042612465477900_b11-0030557","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"key":"2021042612465477900_b12-0030557","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/1097-0142(19940415)73:8<2231::AID-CNCR2820730832>3.0.CO;2-E","article-title":"MYCN gene amplification in rhabdomyosarcoma","volume":"73","author":"Driman","year":"1994","journal-title":"Cancer"},{"key":"2021042612465477900_b13-0030557","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.1890","article-title":"Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers","volume":"14","author":"Engelman","year":"2008","journal-title":"Nat Med"},{"key":"2021042612465477900_b14-0030557","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2353\/ajpath.2006.050872","article-title":"The myxoid\/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells","volume":"168","author":"Engstrom","year":"2006","journal-title":"Am J Pathol"},{"key":"2021042612465477900_b15-0030557","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nmeth727","article-title":"The invertor knock-in conditional chromosomal translocation mimic","volume":"2","author":"Forster","year":"2005","journal-title":"Nat Methods"},{"key":"2021042612465477900_b16-0030557","first-page":"1065","article-title":"Mapping of amplification units in the q13\u201314 region of chromosome 12 in human sarcomas: some amplica do not include MDM2","volume":"4","author":"Forus","year":"1993","journal-title":"Cell Growth Differ"},{"key":"2021042612465477900_b17-0030557","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1128\/MCB.20.14.5019-5031.2000","article-title":"An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene","volume":"20","author":"Fredericks","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2021042612465477900_b18-0030557","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"2021042612465477900_b19-0030557","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/0008-5472.CAN-07-3220","article-title":"Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling","volume":"68","author":"Guo","year":"2008","journal-title":"Cancer Res"},{"key":"2021042612465477900_b20-0030557","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.278.5340.1041","article-title":"Systems for identifying new drugs are often faulty","volume":"278","author":"Gura","year":"1997","journal-title":"Science"},{"key":"2021042612465477900_b21-0030557","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2007.01.016","article-title":"A conditional mouse model of synovial sarcoma: insights into a myogenic origin","volume":"11","author":"Haldar","year":"2007","journal-title":"Cancer Cell"},{"key":"2021042612465477900_b22-0030557","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s11999-008-0340-2","article-title":"Synovial sarcoma: from genetics to genetic-based animal modeling","volume":"466","author":"Haldar","year":"2008","journal-title":"Clin Orthop"},{"key":"2021042612465477900_b23-0030557","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/0008-5472.CAN-08-4127","article-title":"A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice","volume":"69","author":"Haldar","year":"2009","journal-title":"Cancer Res"},{"key":"2021042612465477900_b24-0030557","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc1168","article-title":"Mechanisms of sarcoma development","volume":"3","author":"Helman","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2021042612465477900_b25-0030557","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1560","article-title":"The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas","volume":"13","author":"Hernando","year":"2007","journal-title":"Nat Med"},{"key":"2021042612465477900_b26-0030557","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"2021042612465477900_b27-0030557","first-page":"2198","article-title":"Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas","volume":"5","author":"Hoffmann","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2021042612465477900_b28-0030557","first-page":"2865","article-title":"An RNA-binding protein gene, TLS\/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation","volume":"54","author":"Ichikawa","year":"1994","journal-title":"Cancer Res"},{"key":"2021042612465477900_b29-0030557","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in p53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr Biol"},{"key":"2021042612465477900_b30-0030557","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat Genet"},{"key":"2021042612465477900_b31-0030557","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"2021042612465477900_b32-0030557","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/bjc.1995.447","article-title":"Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas","volume":"72","author":"Karpeh","year":"1995","journal-title":"Br J Cancer"},{"key":"2021042612465477900_b33-0030557","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1101\/gad.1243904","article-title":"Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin","volume":"18","author":"Keller","year":"2004","journal-title":"Genes Dev"},{"key":"2021042612465477900_b34-0030557","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1101\/gad.1244004","article-title":"Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a\/ARF and Trp53 loss of function","volume":"18","author":"Keller","year":"2004","journal-title":"Genes Dev"},{"key":"2021042612465477900_b35-0030557","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.1073\/pnas.96.23.13264","article-title":"cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene","volume":"96","author":"Khan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b36-0030557","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1602","article-title":"A spatially and temporally restricted mouse model of soft tissue sarcoma","volume":"13","author":"Kirsch","year":"2007","journal-title":"Nat Med"},{"key":"2021042612465477900_b37-0030557","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00432-008-0385-3","article-title":"Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype","volume":"134","author":"Kohashi","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021042612465477900_b38-0030557","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1128\/MCB.22.20.7204-7216.2002","article-title":"Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors","volume":"22","author":"Lagutina","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2021042612465477900_b39-0030557","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.1545007","article-title":"Effects of RAS on the genesis of embryonal rhabdomyosarcoma","volume":"21","author":"Langenau","year":"2007","journal-title":"Genes Dev"},{"key":"2021042612465477900_b40-0030557","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1535-6108(02)00056-9","article-title":"The Ewing\u2019s sarcoma oncoprotein EWS\/FLI induces a p53-dependent growth arrest in primary human fibroblasts","volume":"1","author":"Lessnick","year":"2002","journal-title":"Cancer Cell"},{"key":"2021042612465477900_b41-0030557","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1158\/0008-5472.CAN-08-0573","article-title":"EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res"},{"key":"2021042612465477900_b42-0030557","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/carcin\/bgp180","article-title":"Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice","volume":"30","author":"Lin","year":"2009","journal-title":"Carcinogenesis"},{"key":"2021042612465477900_b43-0030557","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1158\/0008-5472.CAN-04-3194","article-title":"Genetic modeling of human rhabdomyosarcoma","volume":"65","author":"Linardic","year":"2005","journal-title":"Cancer Res"},{"key":"2021042612465477900_b44-0030557","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1101\/gad.1300705","article-title":"Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation","volume":"19","author":"List","year":"2005","journal-title":"Genes Dev"},{"key":"2021042612465477900_b45-0030557","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2021042612465477900_b46-0030557","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1038\/sj.onc.1203038","article-title":"Rhabdomyosarcoma-working out the pathways","volume":"18","author":"Merlino","year":"1999","journal-title":"Oncogene"},{"key":"2021042612465477900_b47-0030557","doi-asserted-by":"crossref","first-page":"e8075","DOI":"10.1371\/journal.pone.0008075","article-title":"Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma\/malignant fibrous histiocytoma","volume":"4","author":"Mito","year":"2009","journal-title":"PloS ONE"},{"key":"2021042612465477900_b48-0030557","first-page":"4147","article-title":"In vitro chemosensitivity of human soft tissue sarcoma","volume":"21","author":"Morioka","year":"2001","journal-title":"Anticancer Res"},{"key":"2021042612465477900_b49-0030557","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1073\/pnas.061036798","article-title":"Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM\/hSNF2 alpha","volume":"98","author":"Nagai","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b50-0030557","first-page":"2728","article-title":"Development of rhabdomyosarcoma in HER-2\/neu transgenic p53 mutant mice","volume":"63","author":"Nanni","year":"2003","journal-title":"Cancer Res"},{"key":"2021042612465477900_b51-0030557","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1158\/0008-5472.CAN-08-3723","article-title":"Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma","volume":"69","author":"Nishijo","year":"2009","journal-title":"Cancer Res"},{"key":"2021042612465477900_b52-0030557","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1158\/0008-5472.CAN-08-4041","article-title":"Advances in Ewing\u2019s sarcoma research: where are we now and what lies ahead?","volume":"69","author":"Ordonez","year":"2009","journal-title":"Cancer Res"},{"key":"2021042612465477900_b53-0030557","doi-asserted-by":"crossref","first-page":"e1965","DOI":"10.1371\/journal.pone.0001965","article-title":"EWS\/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing\u2019s sarcoma","volume":"3","author":"Owen","year":"2008","journal-title":"PloS ONE"},{"key":"2021042612465477900_b54-0030557","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/sj.onc.1203572","article-title":"The chimeric FUS\/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice","volume":"19","author":"Perez-Losada","year":"2000","journal-title":"Oncogene"},{"key":"2021042612465477900_b55-0030557","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.semcancer.2005.01.006","article-title":"Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model","volume":"15","author":"Perez-Mancera","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"2021042612465477900_b56-0030557","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/sj.onc.1205220","article-title":"Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice","volume":"21","author":"Perez-Mancera","year":"2002","journal-title":"Oncogene"},{"key":"2021042612465477900_b57-0030557","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/carcin\/bgm107","article-title":"Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development","volume":"28","author":"Perez-Mancera","year":"2007","journal-title":"Carcinogenesis"},{"key":"2021042612465477900_b58-0030557","doi-asserted-by":"crossref","first-page":"11459","DOI":"10.1158\/0008-5472.CAN-05-1696","article-title":"Development of Ewing\u2019s sarcoma from primary bone marrow-derived mesenchymal progenitor cells","volume":"65","author":"Riggi","year":"2005","journal-title":"Cancer Res"},{"key":"2021042612465477900_b59-0030557","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1158\/0008-5472.CAN-05-3979","article-title":"Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma","volume":"66","author":"Riggi","year":"2006","journal-title":"Cancer Res"},{"key":"2021042612465477900_b60-0030557","doi-asserted-by":"crossref","first-page":"12843","DOI":"10.1073\/pnas.0511076103","article-title":"Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor","volume":"103","author":"Rossi","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b61-0030557","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-05-0891","article-title":"A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E","volume":"65","author":"Rubin","year":"2005","journal-title":"Cancer Res"},{"key":"2021042612465477900_b62-0030557","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1158\/0008-5472.CAN-05-3627","article-title":"Contributions of human tumor xenografts to anticancer drug development","volume":"66","author":"Sausville","year":"2006","journal-title":"Cancer Res"},{"key":"2021042612465477900_b63-0030557","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1073\/pnas.93.18.9805","article-title":"The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture","volume":"93","author":"Scheidler","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b64-0030557","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9440(10)63696-6","article-title":"Classification and subtype prediction of adult soft tissue sarcoma by functional genomics","volume":"163","author":"Segal","year":"2003","journal-title":"Am J Pathol"},{"key":"2021042612465477900_b65-0030557","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/nm787","article-title":"Synergism between INK4a\/ARF inactivation and aberrant HGF\/SF signaling in rhabdomyosarcomagenesis","volume":"8","author":"Sharp","year":"2002","journal-title":"Nat Med"},{"key":"2021042612465477900_b66-0030557","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.1037763100","article-title":"Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase","volume":"100","author":"Sommer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b67-0030557","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.2083","article-title":"Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice","volume":"211","author":"Strizzi","year":"2007","journal-title":"J Pathol"},{"key":"2021042612465477900_b68-0030557","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1172\/JCI119152","article-title":"EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing\u2019s sarcoma and primitive neuroectodermal tumor cells","volume":"99","author":"Tanaka","year":"1997","journal-title":"J Clin Invest"},{"key":"2021042612465477900_b69-0030557","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","author":"Taylor","year":"2009","journal-title":"J Clin Invest"},{"key":"2021042612465477900_b70-0030557","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1158\/0008-5472.CAN-05-1276","article-title":"Roscovitine is an effective inducer of apoptosis of Ewing\u2019s sarcoma family tumor cells in vitro and in vivo","volume":"65","author":"Tirado","year":"2005","journal-title":"Cancer Res"},{"key":"2021042612465477900_b71-0030557","doi-asserted-by":"crossref","first-page":"13055","DOI":"10.1073\/pnas.231364798","article-title":"Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression","volume":"98","author":"Toft","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021042612465477900_b72-0030557","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/MCB.00099-07","article-title":"EWS\/FLI-1 induces rapid onset of myeloid\/erythroid leukemia in mice","volume":"27","author":"Torchia","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2021042612465477900_b73-0030557","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1038\/sj.onc.1209749","article-title":"Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice","volume":"25","author":"Tsumura","year":"2006","journal-title":"Oncogene"},{"key":"2021042612465477900_b74-0030557","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1158\/0008-5472.CAN-05-3467","article-title":"The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts","volume":"66","author":"Tzukerman","year":"2006","journal-title":"Cancer Res"},{"key":"2021042612465477900_b75-0030557","first-page":"3042","article-title":"Mutation spectrum of the retinoblastoma gene in osteosarcomas","volume":"54","author":"Wadayama","year":"1994","journal-title":"Cancer Res"},{"key":"2021042612465477900_b76-0030557","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes Dev"},{"key":"2021042612465477900_b77-0030557","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1158\/0008-5472.CAN-09-2543","article-title":"A role for BRCA1 in uterine leiomyosarcoma","volume":"69","author":"Xing","year":"2009","journal-title":"Cancer Res"},{"key":"2021042612465477900_b78-0030557","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/1535-7163.MCT-05-0440","article-title":"The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models","volume":"5","author":"Ying","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2021042612465477900_b79-0030557","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ijrobp.2009.02.052","article-title":"Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma","volume":"74","author":"Yoon","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021042612465477900_b80-0030557","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1158\/0008-5472.CAN-06-4221","article-title":"Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/3\/9-10\/557\/1619344\/557.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/3\/9-10\/557\/1619344\/557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T18:37:19Z","timestamp":1619462239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/3\/9-10\/557\/53454\/Animal-models-of-soft-tissue-sarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":80,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.005223","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,1]]}}}